NCT02858310 2026-03-09
E7 TCR T Cells for Human Papillomavirus-Associated Cancers
National Institutes of Health Clinical Center (CC)
Phase 1/2 Completed
Clinical Trials
49 trialsNCT06263582 2025-08-19
Pharmacokinetics of Intravaginal, Self-administered Artesunate Vaginal Pessaries Among Women in Kenya
UNC Lineberger Comprehensive Cancer Center
Phase 1 Completed
NCT03267680 2025-04-13
IRX-2 Regimen in Treating Women With Cervical Squamous Intraepithelial Neoplasia 3 or Squamous Vulvar Intraepithelial Neoplasia 3
University of Southern California
Phase 2 Terminated
NCT03196180 2025-04-08
Topical Fluorouracil and Imiquimod in Treating Patients With High-Grade Cervical Intraepithelial Neoplasia
National Cancer Institute (NCI)
Phase EARLY_PHASE1 Completed
NCT03084081 2025-04-06
UH3
The Cleveland Clinic
Phase NA Completed
NCT05496231 2025-02-03
A Study on the Immune Response and Safety of an Adjuvanted Human Papillomavirus Vaccine When Given to Healthy Women 16 to 26 Years of Age
GlaxoSmithKline
Phase 1/2 Completed
NCT03493542 2024-12-31
V501-213
Merck Sharp & Dohme LLC
Phase 3 Completed
NCT03721978 2024-10-17
REVEAL 2 Trial (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)
Inovio Pharmaceuticals
Phase 3 Completed
NCT02864147 2024-05-02
Treatment of High-Grade Pre-Neoplastic Cervical Lesions (CIN 2/3)
Yale University
Phase 2 Completed
NCT00667563 2024-03-19
Vaccine Therapy in Preventing HPV in HIV-Positive Women in India
AIDS Malignancy Consortium
Phase 1 Completed
NCT03629886 2024-03-15
Safety and Protective Effect Study of GSK Biologicals' Human Papillomavirus (Types 16, 18) Vaccine, Adsorbed (GSK580299) in Healthy Female Subjects From the HPV-039 Study
GlaxoSmithKline
Phase 4 Completed
NCT02481414 2023-12-18
A Clinical Trial of PepCan to Two Therapy Arms for Treating Cervical High-Grade Squamous Intraepithelial Lesions
University of Arkansas
Phase 2 Completed
NCT04679675 2023-09-18
STEP
Kaiser Permanente
Phase NA Completed
NCT03185013 2023-07-27
REVEAL 1
Inovio Pharmaceuticals
Phase 3 Completed
NCT00873288 2023-03-21
Activating Collaborative CIS Support Via Targeted Provider Mailing
Northwestern University
Phase NA Completed
NCT02206048 2022-07-25
Use of High-Resolution Microendoscopy (HRME) in Patients With Adenocarcinoma In-Situ (AIS) of the Cervix
M.D. Anderson Cancer Center
Phase NA Completed
NCT03438006 2021-09-08
A Post Marketing Surveillance (PMS) Study to Monitor the Safety of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine in Female Chinese Subjects
GlaxoSmithKline
Completed
NCT00577317 2021-06-23
Flexitouch® Home Maintenance Therapy or Standard Home Maintenance Therapy in Treating Patients With Lower-Extremity Lymphedema Caused by Treatment for Cervical Cancer, Vulvar Cancer, or Endometrial Cancer
GOG Foundation
Phase 3 Terminated
NCT02354534 2021-04-28
Intravaginal Artesunate for the Treatment of HPV+ High Grade Cervical Intraepithelial Neoplasia (CIN2/3)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1 Completed
NCT03502798 2021-02-18
Coherence Imaging of the Cervical Epithelium With Scanning a/LCI
Duke University
Phase NA Completed
NCT03510273 2020-11-27
Honduras Liger Thermocoagulator Study
PATH
Phase NA Completed
NCT03355820 2020-11-19
A Follow-up Extension Study to Evaluate the Persistence of Immune Response to GSK Biologicals' HPV Vaccine in Healthy Chinese Female Subjects Who Received Three Doses of the Vaccine in the HPV-058 Study
GlaxoSmithKline
Phase 3 Completed
NCT02005510 2020-09-16
Randomized Trial of In-Home Cervical Cancer Screening in Underscreened Women
University of Washington
Phase NA Completed
NCT02095561 2020-09-09
EMA
Instituto Nacional del Cáncer, Argentina
Phase NA Completed
NCT01928225 2020-06-24
Randomized, Double Blind Trial of the Quadrivalent HPV Vaccine to Improve Responses to LEEP Treatment of Cervical HSIL
University of Witwatersrand, South Africa
Phase 2 Completed
NCT03296566 2020-04-24
The SAFE Study: Satisfaction and Adherence to Follow-Up With Colposcopy Exams
University of British Columbia
Phase NA Completed
NCT01298596 2019-11-12
PHE-LEEP
University of Washington
Phase NA Completed
NCT02067468 2019-09-19
ASCUS-COL
Universidad de Antioquia
Phase NA Completed
NCT00128661 2019-03-08
Vaccine To Prevent Cervical Intraepithelial Neoplasia or Cervical Cancer in Younger Healthy Participants
GlaxoSmithKline
Phase 3 Completed
NCT01544478 2018-11-28
V501 Safety and Efficacy Study in Japanese Women Aged 16 to 26 Years (V501-110)
Merck Sharp & Dohme LLC
Phase 4 Completed
NCT01131312 2018-11-20
Randomized Clinical Trial on Clinical Management of ASCUS and LSIL (ALTS)
National Institutes of Health Clinical Center (CC)
Phase 3 Completed
NCT02814448 2018-11-20
CryoPen
The Cleveland Clinic
Phase NA Completed
NCT00575510 2018-08-23
Intervention to Improve Follow-up of Abnormal Pap Test
The University of Texas Medical Branch, Galveston
Phase NA Completed
NCT00121173 2018-07-20
Vaccine Therapy in Preventing Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1/2 Completed
NCT00988559 2018-07-09
Therapeutic Vaccination for Patients With HPV16+ Cervical Intraepithelial Neoplasia (CIN2/3)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1 Completed
NCT00081263 2017-09-15
Celecoxib in Treating Patients With Cervical Intraepithelial Neoplasia
GOG Foundation
Phase 2 Completed
NCT00337818 2017-05-30
Human Papillomavirus (HPV) Vaccine Consistency and Non-inferiority Trial in Young Adult Women
GlaxoSmithKline
Phase 3 Completed
NCT00973362 2017-01-06
Clinical Evaluation of the APTIMA® HPV Assay Using the TIGRIS® System
Gen-Probe, Incorporated
Phase 3 Completed
NCT00929526 2016-10-20
Extension Study of the Efficacy of the GSK 580299 Vaccine in Japanese Women Vaccinated in the Primary NCT00316693 Study
GlaxoSmithKline
Phase 3 Completed
NCT01256424 2016-05-16
Dose-finding Study of Hexaminolevulinate (HAL) Photodynamic Therapy (PDT) to Treat Cervical Neoplasia
Photocure
Phase 2 Completed
NCT00529464 2016-05-09
Spectroscopy Versus Standard Care in Cervical Cancer Patients
M.D. Anderson Cancer Center
Phase 3 Terminated
NCT01929993 2015-07-23
A Trial of Two Electrosurgical Conizations: Histopathological Analysis of Excision Margins
Oswaldo Cruz Foundation
Phase 3 Completed
NCT00995020 2015-07-10
Efficacy Study of Diathermy Cone Biopsy for the Treatment of Cervical Intraepithelial Lesion
Oswaldo Cruz Foundation
Phase 3 Completed
NCT01405768 2014-07-28
Buffered Lidocaine for Loop Electrosurgical Excision Procedures (LEEPs)
Washington University School of Medicine
Phase 2 Completed
NCT00708942 2013-04-24
Hexaminolevulinate (HAL) Photodynamic Therapy (PDT) of Cervical Intraepithelial Neoplasia (CIN) Grade 1
Photocure
Phase 2 Terminated
NCT01034358 2012-10-23
Immune Response to the Human Papillomavirus Vaccine in Young Women With Inflammatory Bowel Disease
Mayo Clinic
Phase 4 Completed
NCT00316706 2012-09-18
Human Papilloma Virus (HPV) Vaccine Trial in Young Adolescent Women With GlaxoSmithKline Biologicals' (GSK Bio) HPV-16/18 Vaccine
GlaxoSmithKline
Phase 3 Completed
NCT00285207 2010-10-11
Safety and Efficacy of A-007 Topical Gel in the Treatment of High-Grade Squamous Intraepithelial Lesions (HSIL) of the Cervix
Tigris Pharmaceuticals
Phase 2 Completed
NCT00190983 2009-11-20
A Trial for Patients With Advanced/Recurrent Cervical Cancer
Eli Lilly and Company
Phase 2 Completed